abrdn Life Sciences Investors (HQL) officer reports no share ownership
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
abrdn Life Sciences Investors filed an initial insider ownership report for a vice president of abrdn. The filing, dated 12/09/2025 as the event date, identifies the individual as an officer of the fund. The report states in the remarks that no securities are beneficially owned by the reporting person. This Form 3 establishes the officer’s ownership status for regulatory disclosure purposes.
Positive
- None.
Negative
- None.
FAQ
What does this Form 3 filing for HQL report?
It reports that a vice president of abrdn, serving as an officer of abrdn Life Sciences Investors (HQL), has filed an initial ownership statement with no securities beneficially owned.
Who is the reporting person in this HQL Form 3 filing?
The reporting person is identified as an officer of abrdn Life Sciences Investors, holding the title of Vice President.
What is the date of the event requiring this Form 3 for HQL?
The date of the event requiring the statement is listed as 12/09/2025.
Is this Form 3 filed by one or multiple reporting persons for HQL?
The filing box indicates it is a Form filed by One Reporting Person.